Complete regression of subcutaneous and cutaneous metastatic melanoma with high-dose intralesional interleukin 2 in comb...
...Published in Melanoma Research
There are limited treatment options for metastatic melanoma, which is almost universally fatal. We report the successful treatment of 64 of 64 cutaneous and subcutaneous melanoma metastases in three patients using high-dose (22 million units per 1.2 ml) intralesional interleukin 2 (IL-2) in combination with topical imiquimod and a retinoid cream. B...
